Can we Boost Emicizumab Without Increasing Thrombosis Risk? – RPTH Journal
RPTH Journal shared a post on LinkedIn:
”Can we boost emicizumab without increasing thrombosis risk?
Emicizumab transformed hemophilia A care.
But breakthrough bleeding still happens, and treatment options remain imperfect.
A new RPTH study explores a provocative idea:
What if adding low-dose FIX plus FX together could safely enhance emicizumab-driven coagulation?
Here’s the key signal:
Combined FIX/FX supplementation restored coagulation potential to near-normal levels in vitro, in patient samples, and in hemophilia A mice.
Why this is biologically plausible:
- Emicizumab works by bridging FIXa and FX
- More FIX + FX to more ternary complex formation
- ~2× increase in FIX–emicizumab–FX complexes predicted
- Faster clot formation and reduced bleeding in vivo
- Thrombotic markers did not increase in animal models
Translation:
Rather than pushing bypassing agents harder, we may be able to optimize the emicizumab pathway itself.
Big questions for clinicians and researchers:
- Could FIX+FX become an alternative to rFVIIa for breakthrough bleeds?
- Could this strategy reduce treatment burden and dosing frequency?
- How do we balance enhanced hemostasis with real-world thrombosis risk?”
Title: Augmented emicizumab-driven coagulation potential in hemophilia A state by in vitro and in vivo supplementation of combined factors IX and X
Authors: Mitsumasa Osuna, Yuto Nakajima, Eisuke Takami, Hirotoshi Nakano, Keiji Nogami
Find the Full Article on RPTH.”
Stay updated with Hemostasis Today.
-
Apr 1, 2026, 18:46Fritz Torto: Why Every Survivor Has a Duty to Build a Stronger Future for Others
-
Apr 1, 2026, 17:47Akshaya Sharon: Qfitlia as a Shift in Treatment Strategy for Hemophilia A and B
-
Apr 1, 2026, 17:21Antonio Pineda Guerrero: Elevated Lp(a) Raises VTE Risk But Only in the Right Hormonal Context
-
Apr 1, 2026, 17:19Shaik Nayeem Uddin: Clopidogrel and Omeprazole Combination Can Quietly Reduce A Life-Saving Effect
-
Apr 1, 2026, 17:18John Abraham: Breaking the ‘Bleeding Disorder’ Myth About Cirrhosis and Coagulation
-
Apr 1, 2026, 17:17Heghine Khachatryan: Linking Coagulation, Inflammation, and Neurodegeneration In Neuro-Hemostasis Axis
-
Apr 1, 2026, 17:15Chokri Ben Lamine: Differentiating Reactive from Clonal Causes in Adult Neutrophilia
-
Apr 1, 2026, 16:05Gregory Piazza: Discussing the 2026 AHA/ACC Guidelines for Acute PE at ACC.26
-
Apr 1, 2026, 15:31Simon Senanu: A Stepwise Laboratory Approach for aPTT Prolongation